Lv2
110 积分 2025-04-11 加入
Claudin proteins as emerging therapeutic targets for solid tumours
6个月前
已完结
China’s innovation in translational medicine: rethinking early-stage clinical development
7个月前
已完结
Now with oligos: antibody–oligonucleotide conjugates are the new drug modality to watch
8个月前
已完结
Trends in target novelty in oncology R&D
8个月前
已完结
Unveiling the molecular and immunological drivers of antibody–drug conjugates in cancer treatment
8个月前
已完结
Immunotherapy for advanced-stage squamous cell lung cancer: the state of the art and outstanding questions
9个月前
已完结
Fifty years of monoclonals: the past, present and future of antibody therapeutics
1年前
已完结
Metabolites as agents and targets for cancer immunotherapy
1年前
已完结
皖公网安备34019202002308
